dr. verstovsek on jak inhibition in polycythemia vera
Published 6 years ago • 347 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
8:14
two experts discuss jak inhibition in polycythemia vera
-
5:28
polycythemia vera: novel jak inhibitors
-
3:01
improved understanding of jak2 inhibition in polycythemia vera
-
1:49
dr. verstovsek on benefit of ruxolitinib in polycythemia vera
-
1:14
the application of jak inhibitors in the treatment of polycythemia vera and myelofibrosis
-
23:39
expert perspectives: jak inhibitors for polycythemia vera
-
2:07
rationale for jak inhibition in pv
-
1:19
dr. srdan verstovsek on jak2 inhibitors as a treatment for myelofibrosis
-
27:23
interactive case: jak inhibitors for the successful management of polycythemia vera
-
7:35
therapeutic response with jak inhibition in myelofibrosis
-
4:25
srdan verstovsek, md, on predicting resistance to hydroxyurea therapy in polycythemia vera
-
5:11
optimal timing of jak inhibition in myelofibrosis
-
5:18
polycythemia vera: jak2 inhibitor patient selection
-
2:16
dr. verstovsek on limitations of the current treatment landscape of myelofibrosis
-
2:10
dr. verstovsek on accelerated phase myelofibrosis
-
20:53
debate: position of jak2 inhibitors as second line therapy in polycythemia vera
-
10:21
update on jak inhibitor — spleen volume reduction and os - serge verstovsek, md, phd.
-
1:45
dr. verstovsek on the manifest trial with cpi-0610 in myelofibrosis
-
4:31
polycythemia vera: proud-pv trial